After disappointing trial results for cancer treatments, Mural Oncology announced Wednesday it is cutting 90% of its workforce.

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...

Bluebird (Nasdaq: BLUE) said its board unanimously recommended going forward with the acquisition offer from Carlyle and SK ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

Like Johnson & Johnson did during its earnings call the day before, Abbott estimated that global tariffs would end up costing ...

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...

While President Trump and Elon Musk have cut spending on research and grants that fueled the life sciences and climate tech ...

The lab space vacancy rate hit 25 percent across the region during the first quarter, as companies continued to downsize and list new sublease space.

J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...